Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Adma Biologics (ADMA) Income towards Parent Company: 2011-2025

Historic Income towards Parent Company for Adma Biologics (ADMA) over the last 12 years, with Sep 2025 value amounting to $36.4 million.

  • Adma Biologics' Income towards Parent Company rose 1.45% to $36.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $209.4 million, marking a year-over-year increase of 207.41%. This contributed to the annual value of $197.7 million for FY2024, which is 800.00% up from last year.
  • As of Q3 2025, Adma Biologics' Income towards Parent Company stood at $36.4 million, which was up 6.46% from $34.2 million recorded in Q2 2025.
  • Adma Biologics' Income towards Parent Company's 5-year high stood at $111.9 million during Q4 2024, with a 5-year trough of -$18.8 million in Q2 2021.
  • In the last 3 years, Adma Biologics' Income towards Parent Company had a median value of $26.9 million in 2025 and averaged $24.3 million.
  • In the last 5 years, Adma Biologics' Income towards Parent Company plummeted by 49.63% in 2023 and then surged by 1,299.96% in 2024.
  • Quarterly analysis of 5 years shows Adma Biologics' Income towards Parent Company stood at -$16.5 million in 2021, then grew by 28.55% to -$11.8 million in 2022, then slumped by 49.63% to -$17.6 million in 2023, then surged by 734.15% to $111.9 million in 2024, then grew by 1.45% to $36.4 million in 2025.
  • Its Income towards Parent Company was $36.4 million in Q3 2025, compared to $34.2 million in Q2 2025 and $26.9 million in Q1 2025.